Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure
Leong L. Ng(University of Leicester), Christian Mueller(Immutep (Germany)), Eiichi Akiyama(Kumamoto University), Raphael Twerenbold(German Centre for Cardiovascular Research), Daniel C. S. Chan(University of Leicester), Nikola Kozhuharov(University of Bern), Andreas Bergmann(Agostino Gemelli University Polyclinic), Jens Lohrmann(University Hospital of Basel), Carmela Schumacher(University Hospital of Basel), Mattia Arrigo(University Hospital of Zurich), Donald J. L. Jones(University of Leicester), Étienne Gayat(Inserm), Iain Squire(University of Leicester), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Jatinderpal K. Sandhu(University of Leicester), Thong Huy Cao(University of Leicester), Paulene A. Quinn(University of Leicester), Zaid Sabti(University Hospital of Basel), Thomas Herrmann(Boston University), Oliver Hartmann, Joan E. Davies(University of Leicester), Joachim Struck
Cited by 90
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k